testimonial-03 By ef Posted 02/03/2017 In testimonial-032017-02-032017-02-03http://www.nouscom.com/wp-content/uploads/2018/03/artboard-3.pngNouscomhttp://www.nouscom.com/wp-content/uploads/2017/01/client-03.png200px200px Recent PostsAdenoviral-based vaccine promotes neoantigen-specific CD8 + T cell stemness and tumor rejectionVENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens’ PredictionNouscom Poster presentation at ASCO 2022Nouscom Poster presentation at CIMT 2022
